Comparison of LLETZ Versus LEEP for the Treatment of Cervical Dysplasia
Recruiting
N/A
Interventional Study
Cervical Dysplasia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 206 (estimated)
- Sponsor
- Ruhr University of Bochum · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cervical dysplasia is the precursor of cervical cancer. LEEP and LLETZ are standard surgical procedures to treat cervical dysplasia. There is no direct head-to-head comparison between LEEP and LLETZ in the literature regarding oncologic safety, for which complete resection of the dysplastic lesion (so-called 'in-sano resection') is the most appropriate postoperative surrogate parameter. Further cl…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Histologically confirmed High Grade Squamous Intraepithelial Lesion (HSIL)
* Colposcopically visible lesion
* No therapy of the disease so far
Exclusion Criteria:
* Pregnancy of the patient at/after inclusion in the study; pregnancy after conization and before the control af…
Contacts